 |
| BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement. SmallCapVoice.com, Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence. |
|---|
|
   |
| MJNA Sub Announces Groundbreaking Distribution Partnership |
|
 Hot Stock to Watch |
Company: Medical Marijuana, Inc. (Pink Sheets: MJNA)
|
End of Day:
Price: 0.1668
Change (%): + 0.0189 (12.78)
Volume: 36,404,933 |
 |
Medical Marijuana, Inc. Subsidiary, HempMeds® Brasil Announces Groundbreaking Distribution Partnership with Paragon HealthCare BR
Partnership to Provide Expanded Accessibility to RSHO™, the First-Ever Product Approved for Import by Brazilian Government
SAN DIEGO, CA-(Marketwired - January 05, 2017) - Medical Marijuana, Inc. (OTC PINK: MJNA), the first-ever publicly traded cannabis company in the United States, has announced a groundbreaking partnership between their subsidiary, HempMeds® Brasil and Paragon HealthCare BR, one of the leading global wholesale distributors of pharmaceutical products.
The partnership between HempMeds® Brasil and Paragon HealthCare BR will provide countless individuals in need of hemp-based medical service more accessibility to HempMeds® Brasil’s Real Scientific Hemp Oil™ (RSHO™) line of products. Both pioneers in their respective industries, this newfound partnership provides the opportunity to expose the world to a growing range of products that are showing therapeutic value in international markets.
“This new collaboration with Paragon HealthCare BR is another victory for the hemp industry, and most importantly, for the consumer,” said Chief Executive Officer of Medical Marijuana, Inc., Dr. Stuart Titus. “We continue to develop markets, expand partnerships and explore new ways to reach consumers across the globe by providing access to products, like RSHO™, that contain vital nutrients supporting overall health and wellness.”
Continue Reading
|
  |
IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications. |
About Penny Stocks |
|
|
